SRCO 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-03-23

• Below is a summary of the results of operations for the three months ended January 31, 2026, and 2025.

• Revenues totaled $92,162 for the three months ended January 31, 2026, compared to $78,998 for the three months ended January 31, 2025. Revenues were up by $13,164 or 17% due primarily to an increase in merchant financing fees.

• Operating expenses were $294,889 during the three months ended January 31, 2026, compared to $257,270 during the three months ended January 31, 2025, an increase of $37,619, or 15% primarily due to an increase in compensation and related costs of $59,780 offset by a decrease in consulting fees of $1…

• Below is a summary of the results of operations for the nine months ended January 31, 2026, and 2025.

• Revenues totaled $288,157 for the nine months ended January 31, 2026, compared to $168,357 for the nine months ended January 31, 2026. Revenues were up by $119,800 or 71% due primarily to an increase in merchant financing fees.

相对上期删除的文字 · 来源:10-Q · 2025-12-19

• Revenues totaled $195,995 for the six months ended October 31, 2025, compared to $89,359 for the six months ended October 31, 2024. Revenues were up by $106,636 or 119% due primarily to an increase in merchant financing fees and sales of wellness products.

• Operating expenses were $732,234 during the six months ended October 31, 2025, compared to $748,812 during the six months ended October 31, 2024, a decrease of $16,578, or 2% primarily due to an increase in general office expense of $5,729 and increase in consulting fees of $6.280 offset by a decrea…

• As of October 31, 2025, we had an accumulated deficit of $69,927,979 and a total stockholders’ deficit of $12,092,686. The net cash flow used by operations was $541,596 for the six months ended October 31, 2025. This deficit results primarily from our net loss of $993,925 and increases in loans rece…

• We met our cash requirements during the period through revenue of $195,995 and proceed from the sale of common shares $165,000 and proceed from convertible notes $316,000.

• We do not anticipate incurring significant research and development expenditures, and we do not anticipate the sale or acquisition of any significant property, plant or equipment, during the next twelve months. At October 31, 2025, we had 6 full-time employees, one part-time employee, and 2 full-tim…